Paulino Vigil-De Gracia1, José Rojas-Suarez2, Edwin Ramos3, Osvaldo Reyes4, Jorge Collantes5, Arelys Quintero6, Erasmo Huertas7, Andrés Calle8, Eduardo Turcios9, Vicente Y Chon10. 1. Critical Care Unit, Department of Obstetrics and Gynecology, Complejo Hospitalario de la Caja de Seguro Social, Panama City, Panama. Electronic address: pvigild@hotmail.com. 2. Critical Care Unit, Clínica de Maternidad Rafael Calvo, Cartagena, Colombia. 3. Department of Gynecology and Obstetrics, Hospital Universitario Dr Luis Razetti, Barcelona, Venezuela. 4. Unit of Research, Department of Gynecology and Obstetrics, Hospital Santo Tomás, Panama City, Panama. 5. Department of Gynecology and Obstetrics, Hospital Regional de Cojamarca, Cajamarca, Peru. 6. Department of Gynecology and Obstetrics, Hospital José Domingo de Obaldía, David, Panama. 7. Unit of Perinatology, Department of Gynecology and Obstetrics, Instituto Nacional Materno Perinatal, Lima, Peru. 8. Department of Gynecology and Obstetrics, Hospital Carlos Andrade Marín, Quito, Ecuador. 9. Unit of Research, Department of Gynecology and Obstetrics, Hospital Primero de Mayo de Seguridad Social, San Salvador, El Salvador. 10. Department of Gynecology and Obstetrics, Hospital Teodoro Maldonado Carbo, Guayaquil, Ecuador.
Abstract
OBJECTIVE: To describe the maternal outcome among women with eclampsia with and without HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). METHODS: A cross-sectional study of women with eclampsia was undertaken in 14 maternity units in Latin America between January 1 and December 31, 2012. Outcomes were compared between women with and without concomitant HELLP syndrome. Logistic regression analysis was performed to identify independent risk factors of maternal mortality. RESULTS: There were 196 eclampsia cases among 115 038 deliveries; 142 (72.4%) women had eclampsia alone and 54 (27.6%) women had concomitant HELLP syndrome. Severe systolic hypertension (≥160 mm Hg), severe diastolic hypertension (≥110 mm Hg), and hypertensive encephalopathy were significantly more common among women with HELLP than among those with eclampsia alone (P=0.01 for all). There were 8 (4.1%) maternal deaths, all in the group with HELLP syndrome, and 18 (9.1%) perinatal deaths. In a multivariate regression model, maternal mortality was significantly associated with low platelet count and severe systolic hypertension (P<0.05). CONCLUSION: Eclampsia with HELLP syndrome is a dangerous complication associated with pregnancy. Low platelet count secondary to HELLP syndrome and severe systolic hypertension were independently associated with maternal mortality from eclampsia.
OBJECTIVE: To describe the maternal outcome among women with eclampsia with and without HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). METHODS: A cross-sectional study of women with eclampsia was undertaken in 14 maternity units in Latin America between January 1 and December 31, 2012. Outcomes were compared between women with and without concomitant HELLP syndrome. Logistic regression analysis was performed to identify independent risk factors of maternal mortality. RESULTS: There were 196 eclampsia cases among 115 038 deliveries; 142 (72.4%) women had eclampsia alone and 54 (27.6%) women had concomitant HELLP syndrome. Severe systolic hypertension (≥160 mm Hg), severe diastolic hypertension (≥110 mm Hg), and hypertensiveencephalopathy were significantly more common among women with HELLP than among those with eclampsia alone (P=0.01 for all). There were 8 (4.1%) maternal deaths, all in the group with HELLP syndrome, and 18 (9.1%) perinatal deaths. In a multivariate regression model, maternal mortality was significantly associated with low platelet count and severe systolic hypertension (P<0.05). CONCLUSION:Eclampsia with HELLP syndrome is a dangerous complication associated with pregnancy. Low platelet count secondary to HELLP syndrome and severe systolic hypertension were independently associated with maternal mortality from eclampsia.
Authors: Litzi Lazo-Vega; Lilian Toledo-Jaldin; Abraham Badner; José Luis Barriga-Vera; Melany Castro-Monrroy; Anna G Euser; Alison Larrea-Alvarado; Ian Lawrence; Carola Mérida; Rodrigo Mizutani; Yuri Pérez; Sebastian Rocabado; Manfredo Vargas; Vikram Vasan; Colleen G Julian; Lorna G Moore Journal: Lancet Reg Health Am Date: 2022-01-26
Authors: Nicola Vousden; Elodie Lawley; Paul T Seed; Muchabayiwa Francis Gidiri; Shivaprasad Goudar; Jane Sandall; Lucy C Chappell; Andrew H Shennan Journal: PLoS Med Date: 2019-03-29 Impact factor: 11.069
Authors: Doris González-Fernández; Emérita Del Carmen Pons; Delfina Rueda; Odalis Teresa Sinisterra; Enrique Murillo; Marilyn E Scott; Kristine G Koski Journal: Front Public Health Date: 2020-03-24